Cite Filings / STOK / 0001950047-26-002826
Feed Companies Filings Check
Sign in
144

Sale of Securities

Stoke Therapeutics, Inc. · Filed 2026-03-19 · Acc 0001950047-26-002826

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-03-20 144 Sale of Securities
  • 2026-03-19 4 GENERAL COUNSEL & CORP SEC sold 8,895 shares at an average $32.14 ($285,901)
  • 2026-03-19 144 Sale of Securities
  • 2026-03-19 4 CHIEF MEDICAL OFFICER sold 14,311 shares at an average $31.92 ($456,835)
  • 2026-03-19 4 Chief Financial Officer sold 4,578 shares at an average $32.14 ($147,145)
  • 2026-03-19 4 Chief Patient Officer sold 3,712 shares at an average $32.14 ($119,311)
  • 2026-03-13 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…